Gara Jalqabaatti › Kansarii Prostate › Ohio › Columbus
Qorannoo klinikaalii Kansarii Prostate Columbus, OH keessatti
Qorannoo 24 Kansarii Prostate f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University Comprehensive Cancer Center, Columbus
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- fi 8 dabalataa
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- fi 11 dabalataa
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Namoota walitti qabaa jiraSadarkaa 2/3
- Central Ohio Urology Group, Gahanna · Miili 7 fagaatti
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- The Ohio State University, Columbus
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Namoota walitti qabaa jiraSadarkaa 3
- Central Ohio Urology Group, Gahanna · Miili 7 fagaatti
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Columbus
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Namoota walitti qabaa jiraSadarkaa 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- fi 4 dabalataa
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University, Columbus
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University Comprehensive Cancer Center, Columbus
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University, Columbus
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University, Columbus
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Columbus
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University Comprehensive Cancer Center, Columbus
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Central Ohio Urology Group, Gahanna · Miili 7 fagaatti
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 43
- Seattle, WAQorannoo 42
- Washington, DCQorannoo 38
Qorannoo biroo Columbus keessatti
- Kansara Qara'a Non-Small CellQorannoo 57
- Saree OljooQorannoo 40
- Kansarii OvariiQorannoo 39
- Saree (Gosoota Hunda)Qorannoo 38
- Dhibee QaraQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 35
- Luukemiya Limfoositiikii KeessummaaQorannoo 28
- Kansara MetastatikiiQorannoo 27
- Kansa EndometiriyaaliiQorannoo 25
- Myeloma Baay’eeQorannoo 24
- Kansarii ColorectalQorannoo 24
- MelanomaQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.